Workshop on Fragment-based Drug Design
Tuesday, June 11, 2013
Pharmacy Building, KU West Campus
Presentations: Room 2020
Poster Session: School of Pharmacy Atrium
8:00 a.m.- 4:30 p.m.
Biochemists, microbiologists and others who may be working with potential "target" proteins were invited to attend this workshop to learn more about the concepts of Fragment-based Drug Design, and to explore the potential of collaborating with our COBRE core research laboratories to apply this method to their proteins and the biological systems in which they function.
Andrew M. Petros, Ph.D., Associate Research Fellow
Abbvie, Chemical Technologies and Outsourcing, North Chicago, IL
Doug Davies, Ph.D., Senior Project Leader
Emerald Bio, Bainbridge Island, WA
Paul Belcher, Ph.D., GE Healthcare, Piscataway, NJ
Roberto De Guzman, Ph.D., University of Kansas, Lawrence, KS
Susan Egan, Ph.D., University of Kansas, Lawrence, KS
Brian Geisbrecht, Ph.D., University of Missouri-Kansas City, Kansas CIty, MO
Mario Rivera, Ph.D., University of Kansas, Lawrence, KS
Michal Zolkiewski, Ph.D., Kansas State University, Manhattan, KS
Other workshop activities will include core lab Q&A presentations, a roundtable discussion and concurrent sessions on FBDD research techniques.